Introduction: There are only a few clinical data on nononcologic procedures performed with the new Hugo™ robot-assisted surgery (RAS) system. Robot-assisted simple prostatectomy (RASP) is a minimally invasive treatment option for benign prostatic hyperplasia, and it demonstrated equal early functional and better perioperative outcomes as compared with open simple prostatectomy. In this article, we reported the first large series of RASP performed with Hugo RAS system. Methods: This Supplementary Video S1 is a step-by-step description of two different techniques for RASP. We analyzed the data of 20 consecutive patients who underwent RASP at OLV Hospital (Belgium) between February 2022 and March 2023. Patients baseline characteristics, perioperative and pathologic, and 1-month postoperative outcomes were reported, using the median (interquartile range [IQR]) and frequencies, as appropriate. Results: Median age (IQR) and preoperative prostate specific antigen (PSA) were 72 (67-76) years, and 7.7 (5.0-13.4) ng/mL, respectively. A total of 11 patients experienced an episode of preoperative acute urinary retention, and 8 men had an indwelling bladder catheter at the time of the surgery. No intraoperative complication occurred, and there was no need for conversion to open surgery. Median operative and console time were 165 (121-180) and 125 (101-148) minutes. On the first postoperative day the urethral catheter was removed in 80% of the patients. Median length of stay was 3 (3-4) days. Three patients had minor postoperative complications. On final pathology report, median prostate volume was 120 (101-154) g. On postoperative uroflowmetry, median Qmax and postvoid residual were 16 (13-26) mL/s and 15 (0-34) mL, respectively. Conclusions: This series represents the first report of surgical outcomes of RASP executed with Hugo RAS system. Awaiting study with longer follow-up, our study suggests that Hugo RAS has multiple applications, and it can ensure optimal outcomes in nononcologic procedures.

中文翻译：

---

使用 Hugo 机器人辅助手术系统进行机器人辅助简单前列腺切除术的初步经验：两种不同技术的逐步描述。

简介：关于使用新型 Hugo™ 机器人辅助手术 (RAS) 系统进行的非肿瘤手术的临床数据很少。机器人辅助单纯前列腺切除术（RASP）是良性前列腺增生的一种微创治疗选择，与开放式单纯前列腺切除术相比，它表现出相同的早期功能和更好的围手术期结果。在本文中，我们报道了使用 Hugo RAS 系统执行的第一个大型 RASP 系列。方法：该补充视频 S1 逐步描述了两种不同的 RASP 技术。我们分析了 2022 年 2 月至 2023 年 3 月期间在 OLV 医院（比利时）接受 RASP 的连续 20 名患者的数据。使用中位数（四分位距 [IQR]）报告了患者的基线特征、围手术期和病理以及术后 1 个月的结果。 ）和频率（视情况而定）。结果：中位年龄 (IQR) 和术前前列腺特异性抗原 (PSA) 分别为 72 (67-76) 岁和 7.7 (5.0-13.4) ng/mL。共有 11 名患者术前出现急性尿潴留，其中 8 名患者在手术时留置了膀胱导尿管。术中未发生并发症，无需中转开腹手术。中位手术时间和控制台时间分别为 165 (121-180) 和 125 (101-148) 分钟。术后第一天，80% 的患者拔除导尿管。中位住院时间为 3 (3-4) 天。3 名患者术后出现轻微并发症。根据最终病理报告，中位前列腺体积为 120 (101-154) g。术后尿流率测定显示，中位 Qmax 和排尿后残留量分别为 16 (13-26) mL/s 和 15 (0-34) mL。结论：本系列代表了使用 Hugo RAS 系统执行的 RASP 手术结果的第一份报告。我们的研究表明 Hugo RAS 具有多种应用，并且可以确保非肿瘤手术的最佳结果，等待更长时间的随访研究。